FDA approved Cuffix on US market
Mis à jour
Airway Medix SA engages in the research, development and distribution of disposable medical devices. Its products are used in intensive care units and anesthesiology departments. The company offers close suction system, endotracheal tube and oral care medical devices. The company was founded by Elad Einav, Marek Jan Orlowski and Oron David Zachar on September 25, 2013 and is headquartered in Warsaw, Poland.
about: airwaymedix.pl/en,1,o-firmie,14,o-nas
Airway Medix owns 39,23% stake in israeli Biovo which product Cuffix was just approved by FDA. This will have significant impact on income, company image, other projects that waits for be approved.
Airway Medix products in development:
- B-Care Oral Care
- Cuffix
- HyperForm Cuff Platform
Cuffix information: youtube.com/watch?v=u8FxG1neiA0
Cuffix brochure: airwaymedix.pl/upload/products/Cuffix_Brochure.pdf
In 2017 Airway sold technology Airway Medix CSS for about 10M - youtube.com/watch?v=F7Umng0xQNs
about: airwaymedix.pl/en,1,o-firmie,14,o-nas
Airway Medix owns 39,23% stake in israeli Biovo which product Cuffix was just approved by FDA. This will have significant impact on income, company image, other projects that waits for be approved.
Airway Medix products in development:
- B-Care Oral Care
- Cuffix
- HyperForm Cuff Platform
Cuffix information: youtube.com/watch?v=u8FxG1neiA0
Cuffix brochure: airwaymedix.pl/upload/products/Cuffix_Brochure.pdf
In 2017 Airway sold technology Airway Medix CSS for about 10M - youtube.com/watch?v=F7Umng0xQNs
Transaction en cours
Note
prnewswire.com/il/news-releases/biovo-technologies-products-in-covid-19-icu-301153216.htmlNote
I closed this trade as there is no new information I will repositionTrade fermée: ordre d’arrêt atteint
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.